000 01401 a2200373 4500
005 20250517135914.0
264 0 _c20170329
008 201703s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.j337
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpelsberg, Angela
245 0 0 _aContribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cFeb 2017
300 _aj337 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdverse Drug Reaction Reporting Systems
_xstatistics & numerical data
650 0 4 _aDrug Approval
_xeconomics
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xclassification
650 0 4 _aFinancial Management
_xmethods
650 0 4 _aGermany
650 0 4 _aHumans
650 0 4 _aOutcome and Process Assessment, Health Care
650 0 4 _aProduct Surveillance, Postmarketing
_xeconomics
700 1 _aPrugger, Christof
700 1 _aDoshi, Peter
700 1 _aOstrowski, Kerstin
700 1 _aWitte, Thomas
700 1 _aHüsgen, Dieter
700 1 _aKeil, Ulrich
773 0 _tBMJ (Clinical research ed.)
_gvol. 356
_gp. j337
856 4 0 _uhttps://doi.org/10.1136/bmj.j337
_zAvailable from publisher's website
999 _c26859593
_d26859593